肿瘤微环境
重编程
串扰
贝伐单抗
类有机物
下调和上调
癌症研究
神经科学
胶质母细胞瘤
限制
脑瘤
生物
肿瘤进展
计算机科学
振动体
PTEN公司
血管生成
胶质瘤
医学
计算生物学
恶性肿瘤
癌细胞
精密医学
间质细胞
球体
个性化医疗
再生医学
癌症治疗
肿瘤发生
癌症
肿瘤细胞
信号转导
基因敲除
作者
Zixuan Wang,Jie Gao,Junned Chan,Yongcong Fang,Yanmei Zhang,Xin Liu,Jingjing Xia,Heyun Mao,Yuxin Miao,Zhouyuan Ji,Yueming Tian,Jin Gu,Ting Zhang,Dongsheng Kong,Zhuo Xiong
摘要
Glioblastoma (GBM) is an aggressive brain malignancy with a median survival of only 15 months despite current therapeutic interventions. A major obstacle to effective treatment is the intricate tumor microenvironment (TME), which drives tumor progression and therapy resistance. However, existing in vitro models lack micrometer-scale spatial control over multiple cellular components and fail to preserve their dynamic interactions, limiting our understanding of tumor biology and treatment responses. Here, we present a spatially controlled GBM-on-a-chip (scGoC) platform that integrates a novel organoid positioning strategy, enabling the reconstruction of the TME within a 3D matrix at micron-level precision. This platform allows real-time monitoring of dynamic tumor-immune-vascular interactions, providing refined insights into tumor progression and drug responses. Using the scGoC, we demonstrate that endothelial cells not only promote microglial migration toward tumor organoids but also drive their polarization toward an immunosuppressive phenotype, faithfully recapitulating hallmark features of GBM progression. Importantly, the platform reveals a pro-tumorigenic adaptive response to bevacizumab monotherapy, driven by the upregulation of HIF-1 signaling and metabolic reprogramming pathways, providing mechanistic insights into GBM treatment. Collectively, the scGoC establishes a versatile and standardized tool for decoding complex cellular communications and investigating mechanisms of treatment response with broad applicability across cancer research.
科研通智能强力驱动
Strongly Powered by AbleSci AI